Sources has said that the Indian government has stated conditions regarding the indemnity clause contract and is awaiting Moderna’s review, India Today reported.
The Drugs Controller General of India (DCGI) had granted permission to Mumbai-based pharmaceutical firm Cipla to import Moderna COVID-19 vaccine for restricted emergency use in India last month.
(With inputs from ANI and India Today)
